Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation
Abstract
This study examined the effects of androgen suppression therapy (AST) on upper and lower body muscle strength and a range of direct measures of physical performance using a cross-sectional design with 118 men (48 men undertaking AST for prostate cancer and 70 healthy aged-matched controls) from a single tertiary center. Primary end points included muscle strength for the upper- and lower-body; functional performance--repeated chair rise, usual and fast 6-m walk, 6-m backwards walk and 400-m walk time; and dual-energy X-ray absorptiometry assessment--whole body, regional soft tissue composition and bone mineral density (BMD). Men on AST had significantly reduced muscle strength for the upper- and lower-body and impaired functional performance compared to controls (P<0.05). As expected, AST patients had significantly lower whole-body and hip BMD and higher percent of body fat than controls (P<0.05), and tended to have lower whole-body lean mass (-2.3 kg, P=0.077). Appendicular skeletal muscle was positively associated with upper-body (r=0.400-0.606, P<0.001) and lower-body (r=0.549-0.588, P<0.001) muscle strength, and strength was related to functional performance. Men undertaking AST were consistently impaired across a broad range of physical and functional musculoskeletal performance assessments compared with their age-matched normal controls. These findings are relevant for those patients considering AST for subclinical disease management, but whose physical reserve is marginal. Strategies to counter these adverse effects of AST need to be initiated so that independent living and quality of life can be maintained.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Androgen deprivation therapy for prostate cancer results in an abrupt loss of lean body mass and a reduction in muscle strength and endurance.
“androgen deprivation therapy (ADT), which is commonly used as treatment for prostate cancer, results in an abrupt loss of lean body mass accompanied by a reduction in muscle strength and endurance(94, 95).”
From Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable (2019) · cites this paper as [95]
Cites
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184 · see citing works
Exercise capacity and mortality among men referred for exercise testing
Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011858 · Cited by 4,114 · see citing works
Sarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · see citing works
High-Intensity Strength Training in Nonagenarians: Effects on Skeletal Muscle
Fiatarone, M. A. (1990) · JAMA · doi:10.1001/jama.1990.03440220053029 · Cited by 1,593 · see citing works
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455 · see citing works
Newman, A. B., Simonsick, E. M., Naydeck, B. L., Boudreau, R. M., Kritchevsky, S. B., Nevitt, M. C., Pahor, M., Satterfield, S., Brach, J. S., Studenski, S. A., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2018 · Cited by 934 · see citing works
Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry
Heymsfield, S. B., Smith, R. C., Aulet, M., Bensen, B., Lichtman, S. W., Wang, J., & Pierson, R. (1990) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/52.2.214 · Cited by 819 · see citing works
Changes in body composition during androgen deprivation therapy for prostate cancer
Smith, M. R., Finkelstein, J. S., McGovern, F. J., Zietman, A. L., Fallon, M. A., Schoenfeld, D. A., & Kantoff, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8299 · Cited by 697 · see citing works
Strength is a major factor in balance, gait, and the occurrence of falls
Fukagawa, N. K., Wolfson, L., Judge, J., Whipple, R., & King, M. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.special_issue.64 · Cited by 617 · see citing works
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
Saigal, C. S., Gore, J. L., Krupski, T. L., Hanley, J., Schonlau, M., & Litwin, M. S. (2007) · Cancer · doi:10.1002/cncr.22933 · Cited by 542 · see citing works
Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality
Tsai, H. K., D'Amico, A. V., Sadetsky, N., Chen, M., & Carroll, P. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm168 · Cited by 520 · see citing works
D'Amico, A. V., Denham, J. W., Crook, J., Chen, M.-H., Goldhaber, S. Z., Lamb, D. S., Joseph, D., Tai, K.-H., Malone, S., Ludgate, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3369 · Cited by 501 · see citing works
Self-citationInsulin sensitivity during combined androgen blockade for prostate cancer
Smith, M. R., Lee, H., & Nathan, D. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2507 · Cited by 493 · see citing works
Taaffe, D. R., Duret, C., Wheeler, S., & Marcus, R. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb05201.x · Cited by 426 · see citing works
Self-citationBone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer
Greenspan, S. L., Coates, P. S., Sereika, S. M., Nelson, J. B., Trump, D. L., & Resnick, N. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0183 · Cited by 412 · see citing works
Long‐term effects of androgen deprivation therapy in prostate cancer patients
Basaria, S. S., Lieb, J., Tang, A., DeWeese, T. L., Carducci, M. A., Eisenberger, M. A., & Dobs, A. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01551.x · Cited by 359 · see citing works
National Practice Patterns and Time Trends in Androgen Ablation for Localized Prostate Cancer
Cooperberg, M. R., Grossfeld, G. D., Lubeck, D. P., & Carroll, P. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.981 · Cited by 330 · see citing works
Resistance Training and Reduction of Treatment Side Effects in Prostate Cancer Patients
Galvao, D. A., Nosaka, K., Taaffe, D. R., Spry, N. A., Kristjanson, L. J., McGuigan, M. R., Suzuki, K., Yamaya, K., & Newton, R. U. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233803.48691.8b · Cited by 297 · see citing works
Self-citationPerspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge Base
Yancik, R., Ganz, P. A., Varricchio, C. G., & Conley, B. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1147 · Cited by 283 · see citing works
Measuring Fitness in Healthy Older Adults: The Health ABC Long Distance Corridor Walk
Simonsick, E. M., Montgomery, P. S., Newman, A. B., Bauer, D. C., & Harris, T. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.4911247.x · Cited by 275 · see citing works
Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer
Galvao, D. A., Spry, N. A., Taaffe, D. R., Newton, R. U., Stanley, J., Shannon, T., Rowling, C., & Prince, R. L. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07539.x · Cited by 270 · see citing works
Self-citationGalvao, D. A., & Taaffe, D. R. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00494.x · Cited by 246 · see citing works
Self-citationRisk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer
Smith, M. R., Boyce, S. P., Moyneur, É., Duh, M. S., Raut, M. K., & Brandman, J. (2005) · The Journal of Urology · doi:10.1016/s0022-5347(05)00033-9 · Cited by 213 · see citing works
Simonsick, E. M., Fan, E., & Fleg, J. L. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00530.x · Cited by 199 · see citing works
Lee, H., McGovern, K., Finkelstein, J. S., & Smith, M. R. (2005) · Cancer · doi:10.1002/cncr.21381 · Cited by 148 · see citing works
Quality of life, morbidity, and mortality after low trauma hip fracture in men
Pande, I., Scott, D. L., O'Neill, T. W., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.034611 · Cited by 139 · see citing works
Galvao, D. A., Taaffe, D. R., Spry, N. A., & Newton, R. U. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500975 · Cited by 114 · see citing works
Self-citationOsteoporosis during androgen deprivation therapy for prostate cancer
Smith, M. R. (2002) · Urology · doi:10.1016/s0090-4295(02)01579-0 · Cited by 100 · see citing works
Endocrine and immune responses to resistance training in prostate cancer patients
Galvao, D. A., Nosaka, K., Taaffe, D. R., Peake, J. M., Spry, N. A., Suzuki, K., Yamaya, K., McGuigan, M. R., Kristjanson, L. J., & Newton, R. U. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500991 · Cited by 95 · see citing works
Self-citationPhysical Function in Men With Prostate Cancer on Androgen Deprivation Therapy
Clay, C. A., Perera, S., Wagner, J. M., Miller, M. E., Nelson, J. B., & Greenspan, S. L. (2007) · Physical Therapy · doi:10.2522/ptj.20060302 · Cited by 83 · see citing works
Taaffe, D. R., Simonsick, E. M., Visser, M., Volpato, S., Nevitt, M. C., Cauley, J. A., Tylavsky, F., & Harris, T. B. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.10.m934 · Cited by 81 · see citing works
Self-citationLevy, M. E., Perera, S., Londen, G. J. V., Nelson, J. B., Clay, C. A., & Greenspan, S. L. (2008) · Urology · doi:10.1016/j.urology.2007.09.018 · Cited by 60 · see citing works
Strength is a major factor in balance, gait, and the occurrence of falls
WOLFSON, L. I. (1995) · The Journals of Gerontology Series A · Cited by 57 · see citing works
Taaffe, D. R., Lewis, B., & Marcus, R. (1994) · Clinical Physiology · doi:10.1111/j.1475-097x.1994.tb00398.x · Cited by 48 · see citing works
Self-citationGalvão, D. A., Newton, R. U., Taaffe, D. R., & Spry, N. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1104 · Cited by 31 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
CAMPBELL, K. L., WINTERS-STONE, K. M., WISKEMANN, J., MAY, A. M., SCHWARTZ, A. L., COURNEYA, K. S., ZUCKER, D. S., MATTHEWS, C. E., LIGIBEL, J. A., GERBER, L. H., et al. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002116 · Cited by 2,988 · see citing works
Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., & Newton, R. U. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2488 · Cited by 657 · see citing works
Self-citationKeogh, J. W. L., & MacLeod, R. D. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.03.006 · Cited by 209 · see citing works
Winters-Stone, K. M., Dobek, J. C., Bennett, J. A., Dieckmann, N. F., Maddalozzo, G. F., Ryan, C. W., & Beer, T. M. (2015) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2014.08.010 · Cited by 126 · see citing works
McMillan, E. M., & Newhouse, I. J. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-082 · Cited by 120 · see citing works
Winters-Stone, K. M., Neil, S. E., & Campbell, K. L. (2014) · British Journal of Sports Medicine · doi:10.1136/bjsports-2012-091732 · Cited by 98 · see citing works
Uth, J., Hornstrup, T., Christensen, J. F., Christensen, K. B., Jørgensen, N. R., Schmidt, J. F., Brasso, K., Jakobsen, M. D., Sundstrup, E., Andersen, L. L., et al. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3399-0 · Cited by 84 · see citing works
Storer, T. W., Miciek, R., & Travison, T. G. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.104 · Cited by 70 · see citing works
- Authors
- Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., Turner, D., & Newton, R. U.
- Affiliations
- The University of Queensland (AU)
- The University of Western Australia (AU)
- Edith Cowan University (AU)
- Venue
- Prostate Cancer and Prostatic Diseases
- Published
- 2008-10-14
- Volume
- 12
- Issue
- 2
- Pages
- 198-203
- ISSN
- 1365-7852 (ISSN-L)
- 1476-5608
- OpenAlex
- W1990869186
- Cited by
- 198
- References
- 35
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 9 · 2023: 10 · 2022: 12 · 2021: 9 · 2020: 13 · 2019: 12 · 2018: 13 · 2017: 14 · 2016: 8 · 2015: 17 · 2014: 15 · 2013: 23 · 2012: 13
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Prostate Cancer and Prostatic Diseases (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Australasian Journal of Paramedicine (submittedVersion)
- Funders
- Cancer Australia
- Topics
- Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
- Keywords
- androgen deprivation therapy, prostate cancer, muscle strength, functional performance, physical performance, bone mineral density, lean body mass, fat mass, walking performance, quality of life, older men
- MeSH terms
- Aged, Androgen Antagonists, Cross-Sectional Studies, Exercise Therapy, Humans, Gonadotropin-Releasing Hormone, Male, Physical Endurance, Prostatic Neoplasms, Absorptiometry, Photon, Bone Density, Muscle, Skeletal, Muscle Weakness, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review